About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Active Not RecruitingNANCT06620237

BIO|MASTER.CSP Study

The goal of this clinical study is to test the clinical safety and performance of the Amvia pacemakers and the Solia CSP S lead when used for left bundle branch area pacing (LBBAP). The patient popula...

Lead sponsor: Biotronik SE & Co. KG•14 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Biotronik SE & Co. KG

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Standard indication for de novo pacemaker implantation or cardiac resynchronization therapy (CRT)
•Patient is intended for implantation of a pacemaker or CRT-P system with left bundle branch area stimulation
•Ability to understand the nature of the study
•Ability and willingness to perform all follow-up visits at the study site
•Ability and willingness to use the CardioMessenger and acceptance of the BIOTRONIK Home Monitoring concept

Exclusion Criteria

•Enrollment of a patient is not permitted if at least one of the following criteria is fulfilled:
•Planned cardiac surgical procedures or interventional measures other than the study procedure within the next 12 months
•Expected to receive heart transplantation or ventricular assist device within 12 months
•Life-expectancy less than 12 months
•Pregnant or breast feeding
•Age less than 18 years
•Participation in another interventional clinical investigation (according to the definition given in the CIP)

Related studies

Leadless Pacemaker Registry: Outcomes and Follow-up From the University Hospital of St. Pölten

NCT07246135 · Pacemaker, Leadless Pacemaker, and more

Active Not RecruitingNA

Left Bundle Branch Area Pacing in Patients With Heart Failure

NCT06488989 · Heart Failure With Reduced Ejection Fraction, Left Bundle Branch Area Pacing, and more

Clinical Investigation Plan for the AVOPT Data Collection Clinical Study

NCT03049722 · Cardiac Pacemaker, Artificial

COMPLETEDPhase 2/3

Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy.

NCT00399594 · Heart Failure, Congestive, Cardiac Pacing, Artificial, and more

Dual Chamber Versus Single Chamber Cardiac Pacing in People 80 Years of Age and Older

NCT00116987 · Atrial Fibrillation, Cardiac Pacing, Artificial

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 18, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhaseNA

Enrollment152

Start dateOct 2024

Last updatedNov 18, 2025

Condition

Cardiac Pacing, Artificial Cardiac Pacemaker, Artificial Cardiac Resynchronization Therapy Devices Bradycardia Conduction Disorder+2 more

Locations shown

Integral Healthcare

Adelaide

Victorian Heart Hospital

Clayton

Lyell McEwin Hospital

Elizabeth Vale

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 18, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions